ストックスクリーナーアプリを入手
0.1891
4.48%
0.0081
アフターアワーズ：
.19
0.0009
+0.48%
前日終値:
$0.181
開ける：
$0.1756
24時間の取引高:
405.50K
Relative Volume:
0.04
時価総額：
$9.88M
収益：
$598.00K
当期純損益:
$-44.93M
株価収益率:
-0.0228
EPS:
-8.31
ネットキャッシュフロー:
$-17.32M
1週間 パフォーマンス:
+8.43%
1か月 パフォーマンス:
-33.86%
6か月 パフォーマンス:
-82.33%
1年 パフォーマンス:
-91.78%
1日の値動き範囲:
$0.1506
$0.19
1週間の範囲:
$0.1506
$0.1979
52週間の値動き範囲:
$0.1506
$2.625
Ernexa Therapeutics Inc Stock (ERNA) Company Profile
名前
Ernexa Therapeutics Inc
セクター
電話
(212) 582-1199
住所
1035 CAMBRIDGE STREET, CAMBRIDGE
ERNA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ERNA
Ernexa Therapeutics Inc
|
0.1891 | 9.88M | 598.00K | -44.93M | -17.32M | -8.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.62 | 121.88B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.45 | 62.69B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
555.11 | 33.86B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.74 | 30.51B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
238.51 | 25.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Ernexa Therapeutics Inc (ERNA) 最新ニュース
Eterna therapeutics sees $394,174 stock acquisition by Charles Cherington - Investing.com India
Ernexa Therapeutics Closes New Funding Round - GlobeNewswire
Biotech Breakthrough: Ernexa Secures $7.25M to Advance Revolutionary Cancer Treatment - Stock Titan
Brooklyn ImmunoTherapeutics (NYSE:BTX) Earns Hold Rating from Analysts at StockNews.com - MarketBeat
Eterna Therapeutics announces corporate rebranding to Ernexa Therapeutics By Investing.com - Investing.com Australia
Eterna Therapeutics announces corporate rebranding to Ernexa Therapeutics - Investing.com
Eterna Therapeutics Changes Name to Ernexa Therapeutics to - GlobeNewswire
Major Pivot: Eterna Becomes Ernexa, Unveils New Cancer and Autoimmune Disease Strategy - Stock Titan
Brooklyn ImmunoTherapeutics (NYSE:BTX) Coverage Initiated at StockNews.com - Defense World
StockNews.com Initiates Coverage on Brooklyn ImmunoTherapeutics (NYSE:BTX) - MarketBeat
Brooklyn ImmunoTherapeutics (NYSE:BTX) Coverage Initiated by Analysts at StockNews.com - Defense World
StockNews.com Begins Coverage on Brooklyn ImmunoTherapeutics (NYSE:BTX) - MarketBeat
Brooklyn ImmunoTherapeutics Inc (NYSE:BTX) Declares $0.09 Monthly Dividend - MarketBeat
Eterna Therapeutics sets annual meeting date, opens nominations - MSN
Better AI Stock: SoundHound AI vs. Broadcom - The Globe and Mail
Eterna Therapeutics Hosts Successful Inaugural Meeting with - GlobeNewswire
Can Eterna's Expert-Backed Cell Therapy Breakthrough Revolutionize Ovarian Cancer Treatment? - StockTitan
Brooklyn ImmunoTherapeutics (NYSE:BTX) Now Covered by Analysts at StockNews.com - Defense World
Eterna Therapeutics (NASDAQ:ERNA) & Galecto (NASDAQ:GLTO) Head to Head Comparison - Defense World
Eterna Therapeutics Inc (ERNA)’s highs and lows: A closer look at its stock price fluctuations - US Post News
Brooklyn ImmunoTherapeutics (NYSE:BTX) Now Covered by StockNews.com - Defense World
Ratio Examination: Eterna Therapeutics Inc (ERNA)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
ERNA’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
Eterna Therapeutics Inc (ERNA) is a good investment, but the stock may be undervalued - US Post News
Contrasting Eterna Therapeutics (NASDAQ:ERNA) and Anixa Biosciences (NASDAQ:ANIX) - Defense World
Market Insight: Eterna Therapeutics Inc (ERNA)’s Notable Drop, Closing at 0.36 - The Dwinnex
Eterna Therapeutics expands scientific board with oncology experts - MSN
Eterna Therapeutics’ Shares Surge After Promising Preclinical Results for ERNA-101 Cell Therapy - HPBL
Eterna Therapeutics expands scientific board with oncology experts By Investing.com - Investing.com Canada
Eterna Therapeutics Announces Expansion of Scientific Advisory Board - GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Ernexa Therapeutics Inc (ERNA) 財務データ
収益
当期純利益
現金流量
EPS
3.01%
大文字化:
|
ボリューム (24 時間):